Author name: admin

Uncategorized

New Releases from NCBI BookshelfVorasidenib (Voranigo): Indication: For the treatment of Grade 2 (World Health Organization [WHO] 2016, 2021 grading system) astrocytoma or oligodendroglioma with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation or isocitrate dehydrogenase-2 (IDH2) mutation in adults and pediatric patients aged 12 years and older following surgical intervention: Reimbursement Recommendation [Internet].​Vorasidenib (Voranigo): Indication: For the treatment of Grade 2 (World Health Organization [WHO] 2016, 2021 grading system) astrocytoma or oligodendroglioma with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation or isocitrate dehydrogenase-2 (IDH2) mutation in adults and pediatric patients aged 12 years and older following surgical intervention: Reimbursement Recommendation [Internet].

Canada’s Drug Agency (CDA-AMC) recommends that Voranigo be reimbursed by public drug plans for patients aged 12 years and older

Uncategorized

New Releases from NCBI BookshelfRelative and bedside nurse assessment of comfort and communication during propofol, dexmedetomidine, or clonidine-based sedation: pre-planned analysis within the A2B RCT [Internet].​Relative and bedside nurse assessment of comfort and communication during propofol, dexmedetomidine, or clonidine-based sedation: pre-planned analysis within the A2B RCT [Internet].

Optimising comfort and ability to communicate for mechanically ventilated intensive care unit patients is a priority for clinicians, intensive care

Scroll to Top